Adalimumab-psoriasis and Small Bowel Lesions

NCT01556672 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Innovaderm Research Inc.

Collaborators